Infectious Disease and Microbiology – Gemella Species

Overview

Gemella species are Gram-positive cocci that are part of the normal human mucosal flora but occasionally cause invasive disease. Human infections are rare, with infective endocarditis and bacteremia representing the most important clinical manifestations.

An important microbiologic feature is that Gemella can be misidentified as viridans group streptococci, particularly with conventional laboratory methods.

Important Species

Clinically important species include:

• Gemella haemolysans

• Gemella morbillorum

Both have been associated with invasive infections, particularly endocarditis.

Microbiologic Characteristics

Gemella species are:

• Gram-positive cocci

• Facultatively anaerobic

• Catalase-negative

• Often arranged in pairs, short chains, or clusters

• Occasionally Gram-variable on staining

Because of their appearance and biochemical characteristics, isolates may be confused with viridans streptococci.

Normal Flora

Gemella species may colonize normal human mucosal surfaces, particularly the:

• Oral cavity

• Upper respiratory tract

• Gastrointestinal tract

Therefore, invasive infection may develop when organisms gain access to the bloodstream through disrupted mucosal surfaces.

Epidemiology

Gemella species have a worldwide distribution, but clinically significant infections are uncommon.

Most reported disease represents opportunistic or endogenous infection arising from the patient’s own colonizing flora.

Endocarditis

The most important invasive infection caused by Gemella is:

Infective endocarditis

Endocarditis may occur after transient or sustained bacteremia, potentially originating from the oral cavity or gastrointestinal tract.

Clinical manifestations may include:

• Fever

• Malaise

• New or changing cardiac murmur

• Persistent bacteremia

• Embolic phenomena

Association With Oral Disease

Because Gemella can inhabit the oral cavity, some cases of endocarditis have been associated with:

• Poor dentition

• Dental infection

• Recent dental procedures

• Other disruption of oral mucosal integrity

This clinical pattern can resemble endocarditis caused by viridans streptococci.

Bacteremia

Gemella species can cause bacteremia, either as an isolated bloodstream infection or in association with a deeper infectious focus such as endocarditis.

Persistent positive blood cultures should prompt investigation for an underlying source.

Pneumonia

Rare cases of pneumonia associated with Gemella species have been reported.

Because the organism may colonize the upper respiratory tract, isolation from respiratory material must be interpreted within the clinical context.

Urinary Tract Infection

Gemella species have occasionally been recovered from patients with urinary tract infections, although this is an uncommon manifestation.

Wound Infection and Abscesses

Rare infections include:

• Wound infection

• Soft-tissue infection

• Abscess formation

As with other organisms originating from normal flora, disruption of tissue barriers may facilitate invasive disease.

Prosthetic Joint Infection

Gemella species have rarely caused infections involving total knee arthroplasties and other prosthetic joints.

Prosthetic-device infection may require:

Antimicrobial therapy

• ●

Appropriate surgical/source control

depending on the clinical circumstances.

Arteriovenous Shunt Infection

Rare cases involving arteriovenous shunts have also been described.

This demonstrates the ability of Gemella species to cause infections involving implanted or intravascular medical material.

Diagnosis

Diagnosis is established primarily by:

Culture

Blood cultures are particularly important when bacteremia or endocarditis is suspected.

Laboratory Identification

A major diagnostic issue is potential confusion between:

Gemella species

and

Viridans group streptococci

Modern identification methods can improve species-level recognition when conventional biochemical testing is inconclusive.

Diagnosis of Endocarditis

When Gemella is repeatedly isolated from blood cultures, particularly in a patient with compatible symptoms, evaluation for infective endocarditis should be considered.

This generally involves:

Repeated blood cultures

• ●

Echocardiographic evaluation

• ●

Assessment for embolic or other complications

Treatment

The source lists:

Penicillin G

as the primary treatment.

Many Gemella isolates have historically demonstrated susceptibility to β-lactam antibiotics, although susceptibility testing is useful in significant invasive disease.

Additional Treatment

Alternative agents listed in the source include:

• Vancomycin

• Macrolides

For serious infections such as endocarditis, antimicrobial therapy should be selected according to susceptibility results and the clinical syndrome.

High-Yield Clinical Pattern

Gram-positive coccus

• ●

May be mistaken for viridans streptococci

• ●

Bacteremia

• ●

Infective endocarditis

→ Think Gemella species

Endocarditis Pattern

Oral flora organism

• ●

Possible dental/oral source

• ●

Persistent bacteremia

• ●

Cardiac valve vegetation

→ Consider Gemella endocarditis

Gemella vs. Viridans Streptococci

Gemella:

Gram-positive/occasionally Gram-variable cocci + rare invasive pathogen + important association with endocarditis

Viridans streptococci:

Gram-positive cocci + common oral flora + classic cause of subacute endocarditis

The two may appear similar with conventional microbiologic testing.

Exam Essentials

Genus: Gemella

Important species: G. haemolysans, G. morbillorum

Morphology: Gram-positive cocci

Distribution: Worldwide

Frequency of infection: Rare

Normal habitat: Primarily oral and other mucosal flora

Important diagnostic confusion: Viridans streptococci

Major infection: Endocarditis

Other major manifestation: Bacteremia

Rare infections: Pneumonia, UTI, wound infection, abscesses

Device infections: Prosthetic joint and arteriovenous shunt infection

Diagnosis: Culture

Treatment in source: Penicillin G

Additional agents: Vancomycin, macrolides

Management principle: Susceptibility-guided treatment for serious invasive disease

Key clinical pearl: Gemella is a rare Gram-positive coccus that can resemble viridans streptococci in the laboratory. Its most important invasive association is infective endocarditis, often fitting the clinical pattern of an oral-flora organism producing bacteremia and valvular infection.

Infectious Disease and Microbiology – Gardnerella vaginalis

Overview

Gardnerella vaginalis is a small, pleomorphic bacterium strongly associated with bacterial vaginosis (BV). BV results from disruption of the normal vaginal microbiota, with loss of protective Lactobacillus predominance and overgrowth of Gardnerella together with other anaerobic organisms.

Although primarily associated with bacterial vaginosis, G. vaginalis can occasionally cause postpartum endometritis, urinary tract infection, and bacteremia.

Microbiologic Characteristics

Gardnerella vaginalis is:

• A small pleomorphic bacillus/coccobacillus

• Facultatively anaerobic

• Gram-variable, rather than reliably Gram-negative

• Associated with polymicrobial vaginal biofilms

The source describes it as an aerobic Gram-negative bacillus, but Gram-variable coccobacillus/facultative anaerobe is a more accurate microbiologic description.

Epidemiology

G. vaginalis occurs worldwide.

Importantly, Gardnerella may be present in the vaginal microbiota without producing symptoms. Therefore, simply detecting the organism does not by itself establish bacterial vaginosis.

BV reflects a broader vaginal microbial dysbiosis rather than infection by G. vaginalis alone.

Bacterial Vaginosis

The most important clinical association is:

Gardnerella vaginalis → bacterial vaginosis

In BV, normal hydrogen-peroxide/lactic-acid-producing lactobacilli decrease and are replaced by increased concentrations of Gardnerella and multiple anaerobic organisms.

Clinical Features of Bacterial Vaginosis

Typical manifestations include:

• Thin, homogeneous vaginal discharge

• White or gray discharge

• Characteristic fishy odor

• Minimal vaginal inflammation in many patients

Pruritus and marked inflammatory changes are less characteristic than in vulvovaginal candidiasis or trichomoniasis.

Clue Cells

A classic microscopic finding is the:

Clue cell

Clue cells are vaginal epithelial cells whose surfaces are densely coated with bacteria, producing indistinct or stippled cellular borders.

They are strongly associated with bacterial vaginosis.

Amsel Criteria

A classic clinical diagnosis of bacterial vaginosis can be made using the Amsel criteria.

The findings are:

• Thin, homogeneous vaginal discharge

• Vaginal pH >4.5

• Positive amine (“whiff”) test after adding potassium hydroxide

• Clue cells on microscopy

The presence of at least 3 of the 4 criteria supports the diagnosis of bacterial vaginosis.

Fishy Odor

The characteristic odor results from volatile amines produced by the altered vaginal microbial community.

The odor may become more apparent after adding potassium hydroxide during the whiff test.

Postpartum Endometritis

G. vaginalis has also been implicated in postpartum endometritis.

These infections are frequently polymicrobial and may involve organisms originating from the lower genital tract.

Urinary Tract Infection

Urinary infection associated with G. vaginalis has been reported, including in pregnant women.

Because the organism may colonize the genital tract, its recovery from urinary specimens should be interpreted together with symptoms and specimen quality.

Bacteremia

Although uncommon, G. vaginalis can cause bacteremia and other invasive infections.

Systemic infection is much less common than bacterial vaginosis.

Diagnosis

The source describes:

• Culture using specific media

• Identification of clue cells on vaginal smears

For bacterial vaginosis, however, routine culture of G. vaginalis is generally not the preferred diagnostic strategy because the organism can also occur in people without BV.

Gram Stain

A vaginal Gram stain can be assessed using the Nugent scoring system, which evaluates changes in vaginal bacterial morphotypes.

A pattern showing decreased lactobacilli with increased organisms characteristic of BV supports the diagnosis.

Treatment of Bacterial Vaginosis

The source emphasizes:

Metronidazole

as highly effective for bacterial vaginosis.

Metronidazole works well clinically because BV is a polymicrobial syndrome involving anaerobic organisms, even though susceptibility testing of G. vaginalis alone may not fully predict clinical response.

Topical Treatment

The source also describes local treatment with:

• Metronidazole

• Clindamycin

These can be administered as vaginal preparations for bacterial vaginosis.

Additional Treatment

Additional antimicrobial options described in the source include:

• Amoxicillin–clavulanate

• Clindamycin

For systemic or urinary infections, the source recommends:

• Ampicillin

• Amoxicillin

Treatment of invasive infection should be individualized according to the clinical syndrome and antimicrobial susceptibility information.

Important Clinical Distinction

Bacterial vaginosis is generally characterized by:

Altered vaginal flora + discharge + fishy odor

rather than prominent inflammation.

Therefore:

BV → vaginosis rather than classic inflammatory vaginitis

This helps distinguish it from conditions such as candidiasis and trichomoniasis.

High-Yield Clinical Pattern

Thin, homogeneous gray-white vaginal discharge

• ●

Fishy odor

• ●

Vaginal pH >4.5

• ●

Clue cells

→ Think bacterial vaginosis associated with Gardnerella vaginalis

Exam Essentials

Organism: Gardnerella vaginalis

Morphology: Small pleomorphic Gram-variable coccobacillus

Metabolism: Facultatively anaerobic

Distribution: Worldwide

Major association: Bacterial vaginosis

Pathogenesis: Loss of Lactobacillus predominance + polymicrobial overgrowth/biofilm

Discharge: Thin, homogeneous, gray-white

Characteristic odor: Fishy

Vaginal pH: >4.5

Microscopy: Clue cells

Whiff test: Positive

Clinical diagnostic method: Amsel criteria

Gram-stain method: Nugent score

Other infections: Postpartum endometritis, UTI, bacteremia

Main treatment in source: Metronidazole

Alternative BV treatment: Clindamycin

Culture: Not generally required to diagnose routine BV

Bacterial Vaginosis vs. Candidiasis

Bacterial vaginosis:

Thin gray-white discharge + fishy odor + pH >4.5 + clue cells

Vulvovaginal candidiasis:

Thick white discharge + prominent pruritus/inflammation + usually normal vaginal pH + yeast/pseudohyphae

Key clinical pearl: Gardnerella vaginalis is strongly associated with bacterial vaginosis, but BV is a polymicrobial dysbiosis rather than a simple single-organism infection. The classic examination combination is thin gray-white discharge, fishy odor, vaginal pH >4.5, and clue cells.

Microbiologic Characteristics Gardnerella vaginalis is: • A small pleomorphic bacillus/coccobacillus

• Facultatively anaerobic

• Gram-variable, rather than reliably Gram-negative

• Associated with polymicrobial vaginal biofilms The source describes it as an aerobic Gram-negative bacillus, but Gram-variable coccobacillus/facultative anaerobe is a more accurate microbiologic description.

Epidemiology G. vaginalis occurs worldwide. Importantly, Gardnerella may be present in the vaginal microbiota without producing symptoms. Therefore, simply detecting the organism does not by itself establish bacterial vaginosis. BV reflects a broader vaginal microbial dysbiosis rather than infection by G. vaginalis alone.

Bacterial Vaginosis The most important clinical association is: Gardnerella vaginalis → bacterial vaginosis In BV, normal hydrogen-peroxide/lactic-acid-producing lactobacilli decrease and are replaced by increased concentrations of Gardnerella and multiple anaerobic organisms.

Clinical Features of Bacterial Vaginosis Typical manifestations include: • Thin, homogeneous vaginal discharge

• White or gray discharge

• Characteristic fishy odor

• Minimal vaginal inflammation in many patients Pruritus and marked inflammatory changes are less characteristic than in vulvovaginal candidiasis or trichomoniasis.

Clue Cells A classic microscopic finding is the: Clue cell Clue cells are vaginal epithelial cells whose surfaces are densely coated with bacteria, producing indistinct or stippled cellular borders. They are strongly associated with bacterial vaginosis.

Amsel Criteria A classic clinical diagnosis of bacterial vaginosis can be made using the Amsel criteria. The findings are: • Thin, homogeneous vaginal discharge

• Vaginal pH >4.5

• Positive amine (“whiff”) test after adding potassium hydroxide

• Clue cells on microscopy The presence of at least 3 of the 4 criteria supports the diagnosis of bacterial vaginosis.

Fishy Odor The characteristic odor results from volatile amines produced by the altered vaginal microbial community. The odor may become more apparent after adding potassium hydroxide during the whiff test.

Postpartum Endometritis G. vaginalis has also been implicated in postpartum endometritis. These infections are frequently polymicrobial and may involve organisms originating from the lower genital tract.

Urinary Tract Infection Urinary infection associated with G. vaginalis has been reported, including in pregnant women. Because the organism may colonize the genital tract, its recovery from urinary specimens should be interpreted together with symptoms and specimen quality.

Bacteremia Although uncommon, G. vaginalis can cause bacteremia and other invasive infections. Systemic infection is much less common than bacterial vaginosis.

Diagnosis The source describes: • Culture using specific media

• Identification of clue cells on vaginal smears For bacterial vaginosis, however, routine culture of G. vaginalis is generally not the preferred diagnostic strategy because the organism can also occur in people without BV.

Gram Stain A vaginal Gram stain can be assessed using the Nugent scoring system, which evaluates changes in vaginal bacterial morphotypes. A pattern showing decreased lactobacilli with increased organisms characteristic of BV supports the diagnosis.

Treatment of Bacterial Vaginosis The source emphasizes: Metronidazole as highly effective for bacterial vaginosis. Metronidazole works well clinically because BV is a polymicrobial syndrome involving anaerobic organisms, even though susceptibility testing of G. vaginalis alone may not fully predict clinical response.

Topical Treatment The source also describes local treatment with: • Metronidazole

• Clindamycin These can be administered as vaginal preparations for bacterial vaginosis.

Additional Treatment Additional antimicrobial options described in the source include: • Amoxicillin–clavulanate

• Clindamycin For systemic or urinary infections, the source recommends: • Ampicillin

• Amoxicillin Treatment of invasive infection should be individualized according to the clinical syndrome and antimicrobial susceptibility information.

Important Clinical Distinction Bacterial vaginosis is generally characterized by: Altered vaginal flora + discharge + fishy odor rather than prominent inflammation. Therefore: BV → vaginosis rather than classic inflammatory vaginitis This helps distinguish it from conditions such as candidiasis and trichomoniasis.

High-Yield Clinical Pattern Thin, homogeneous gray-white vaginal discharge  ●  Fishy odor  ●  Vaginal pH >4.5  ●  Clue cells → Think bacterial vaginosis associated with Gardnerella vaginalis

Exam Essentials Organism: Gardnerella vaginalis

Morphology: Small pleomorphic Gram-variable coccobacillus

Metabolism: Facultatively anaerobic

Distribution: Worldwide

Major association: Bacterial vaginosis

Pathogenesis: Loss of Lactobacillus predominance + polymicrobial overgrowth/biofilm

Discharge: Thin, homogeneous, gray-white

Characteristic odor: Fishy

Vaginal pH: >4.5

Microscopy: Clue cells

Whiff test: Positive

Clinical diagnostic method: Amsel criteria

Gram-stain method: Nugent score

Other infections: Postpartum endometritis, UTI, bacteremia

Main treatment in source: Metronidazole

Alternative BV treatment: Clindamycin

Culture: Not generally required to diagnose routine BV

Bacterial Vaginosis vs. Candidiasis Bacterial vaginosis:

Thin gray-white discharge + fishy odor + pH >4.5 + clue cells Vulvovaginal candidiasis:

Thick white discharge + prominent pruritus/inflammation + usually normal vaginal pH + yeast/pseudohyphae

Key clinical pearl: Gardnerella vaginalis is strongly associated with bacterial vaginosis, but BV is a polymicrobial dysbiosis rather than a simple single-organism infection. The classic examination combination is thin gray-white discharge, fishy odor, vaginal pH >4.5, and clue cells.

Infectious Disease and Microbiology – Fusobacterium Species

Overview

Fusobacterium species are anaerobic Gram-negative bacilli that normally colonize the oral cavity and gastrointestinal tract. Most infections are endogenous, developing when organisms from the patient’s normal flora invade normally sterile tissues.

They commonly participate in polymicrobial abscesses and necrotizing infections. A particularly important species is Fusobacterium necrophorum, which is classically associated with Lemierre syndrome—postpharyngitis sepsis with internal jugular vein septic thrombophlebitis and metastatic infection.

⸻

Important Species

Species traditionally included in this group include:

• Fusobacterium alocis

• Fusobacterium mortiferum

• Fusobacterium necrophorum

• Fusobacterium nucleatum

• Fusobacterium periodonticum

• Fusobacterium sulci

• Fusobacterium ulcerans

• Fusobacterium varium

• Other Fusobacterium species

F. necrophorum and F. nucleatum are particularly important in human infectious disease.

⸻

Microbiologic Characteristics

Fusobacterium species are:

• Gram-negative bacilli

• Obligate anaerobes

• Common members of normal oral and gastrointestinal flora

• Important causes of endogenous anaerobic infection

The organisms are often described morphologically as slender or fusiform Gram-negative rods.

⸻

Incubation and Source of Infection

A conventional incubation period is generally not applicable because most infections originate from the patient’s own microbial flora.

The typical sequence is:

Normal oral or bowel colonization

→

Mucosal disruption or local infection

→

Invasion of deeper tissue

→

Abscess, bacteremia, or metastatic infection

⸻

Epidemiology

Fusobacterium species commonly colonize the:

• Oral cavity

• Oropharynx

• Gastrointestinal tract

Their presence as normal flora means that infection commonly develops when anatomic barriers are disrupted.

⸻

Clinical Infections

Fusobacterium species can cause:

• Cervicofacial infections

• Pleuropulmonary infections

• Intra-abdominal infections

• Pelvic infections

• Soft-tissue infections

• Surgical wound infections

• Bite-wound infections

• Bacteremia and sepsis

• Endocarditis

Abscesses are common and are frequently polymicrobial.

⸻

Cervicofacial Infection

Because Fusobacterium commonly inhabits the oral cavity, it can participate in cervicofacial and odontogenic infections.

These infections may include:

• Dental and periodontal infection

• Deep neck-space infection

• Peritonsillar infection

• Cervicofacial abscess formation

⸻

Pleuropulmonary Infection

Aspiration of oral secretions containing anaerobic organisms may result in:

• Aspiration pneumonia

• Lung abscess

• Necrotizing pulmonary infection

• Empyema

These infections are frequently polymicrobial and may include other anaerobic components of the oral flora.

⸻

Intra-Abdominal and Pelvic Infection

Because fusobacteria can form part of gastrointestinal flora, they may participate in:

• Intra-abdominal abscesses

• Peritonitis

• Pelvic abscesses

• Other polymicrobial abdominal infections

Source control is often important when an abscess is present.

⸻

Soft-Tissue and Wound Infection

Fusobacterium species can cause soft-tissue and wound infections, including infections following:

• Surgery

• Human or animal bites

• Tissue trauma

These infections commonly involve multiple aerobic and anaerobic organisms.

⸻

Lemierre Syndrome

The most important high-yield association is:

Fusobacterium necrophorum → Lemierre syndrome

This condition classically develops in an otherwise healthy adolescent or young adult following pharyngitis or tonsillitis.

⸻

Pathogenesis of Lemierre Syndrome

The classic progression is:

Acute pharyngitis/tonsillitis

→

Spread into the lateral pharyngeal tissues

→

Internal jugular vein septic thrombophlebitis

→

Fusobacterial bacteremia

→

Septic emboli to distant organs

The lungs are particularly commonly involved.

⸻

Clinical Features of Lemierre Syndrome

Patients may initially have:

• Severe sore throat

• Fever

• Tonsillitis or pharyngitis

They may subsequently develop:

• Persistent or recurrent high fever

• Sepsis

• Unilateral neck pain or swelling

• Tenderness along the internal jugular vein

• Respiratory symptoms from septic pulmonary emboli

⸻

Septic Pulmonary Emboli

Infected thrombus within the internal jugular vein can release septic emboli into the bloodstream.

These frequently travel to the lungs and may produce:

• Multiple pulmonary nodules

• Cavitary lesions

• Pulmonary abscesses

• Pleural infection

• Respiratory distress

This pulmonary pattern is an important clue to Lemierre syndrome.

⸻

Other Metastatic Abscesses

Hematogenous dissemination may also produce abscesses involving:

• Bones

• Joints

• Central nervous system

• Other distant organs

Thus, F. necrophorum can produce a severe metastatic septic illness after an initially localized throat infection.

⸻

Endocarditis

Fusobacterium species can rarely cause infective endocarditis.

Persistent bacteremia or appropriate cardiac findings should prompt consideration of endovascular infection.

⸻

Diagnosis

Diagnosis is established using:

Anaerobic culture

Appropriate specimens may include:

• Blood

• Abscess material

• Pleural fluid

• Deep tissue specimens

Proper anaerobic collection and transport are important for recovery of the organism.

⸻

Diagnosis of Lemierre Syndrome

When Lemierre syndrome is suspected, evaluation typically aims to demonstrate:

Septic thrombosis of the internal jugular vein

along with evidence of infection.

Imaging of the neck can demonstrate the thrombosed vein, while chest imaging may identify septic pulmonary emboli or abscesses.

⸻

Treatment

The source lists:

Metronidazole

and

Penicillin G

as principal antimicrobial options.

Therapy should provide adequate anaerobic coverage and be guided by the clinical syndrome and susceptibility information when available.

⸻

Additional Treatment

Additional agents listed in the source include:

• Clindamycin

• Cefotetan

• Cefoxitin

• Imipenem

• Meropenem

• Chloramphenicol

For severe polymicrobial infection, antimicrobial therapy should also adequately cover other likely pathogens.

⸻

Source Control

Abscess-forming infections frequently require source control in addition to antimicrobial therapy.

This may include:

• Drainage of abscesses

• Surgical debridement

• Management of infected wounds

• Treatment of the underlying dental or abdominal source

⸻

High-Yield Clinical Pattern

Previously healthy adolescent or young adult

Recent pharyngitis

High fever/sepsis

Unilateral neck pain or swelling

Internal jugular vein thrombophlebitis

Multiple septic pulmonary emboli

→ Think Lemierre syndrome due to Fusobacterium necrophorum

⸻

Exam Essentials

Genus: Fusobacterium

Type: Gram-negative bacillus

Oxygen requirement: Anaerobic

Morphology: Often slender/fusiform rods

Normal habitat: Oral and gastrointestinal flora

Usual source: Endogenous infection

Abscesses: Frequently polymicrobial

Major infections: Cervicofacial, pulmonary, abdominal, pelvic, soft-tissue and wound infections

Key species: F. necrophorum

Classic syndrome: Lemierre syndrome

Initial infection: Pharyngitis/tonsillitis

Major vascular complication: Internal jugular vein septic thrombophlebitis

Major metastatic site: Lungs → septic pulmonary emboli/abscesses

Other metastatic sites: Bone and CNS

Diagnosis: Anaerobic culture; imaging is important in Lemierre syndrome

Treatment in source: Metronidazole or penicillin G

Additional agents: Clindamycin, cephamycins, carbapenems

Management principle: Appropriate anaerobic therapy + source control

⸻

Key clinical pearl: The classic association is Fusobacterium necrophorum → Lemierre syndrome: pharyngitis in a young patient followed by sepsis, internal jugular vein septic thrombophlebitis, and septic pulmonary emboli.

Infectious Disease and Microbiology – Fusarium Species

Overview

Fusarium species are filamentous molds with septate hyphae that are widely distributed in the environment. Human infection ranges from localized skin, ocular, bone, and joint disease to severe disseminated fusariosis, particularly in profoundly immunocompromised or neutropenic patients.

A particularly important feature of disseminated Fusarium infection is the combination of fungemia and multiple cutaneous lesions, which can help distinguish it clinically from invasive aspergillosis.

Important Species

Clinically important species traditionally include:

• Fusarium solani

• Fusarium oxysporum

• Fusarium moniliforme

• Other Fusarium species

Several Fusarium organisms are now classified within species complexes, and some older species names have undergone taxonomic revision.

Microbiologic Characteristics

Fusarium species are:

• Filamentous fungi (molds)

• Characterized by septate hyphae

• Hyaline rather than dematiaceous molds

• Widely distributed environmental organisms

They may be found in soil, plants, and organic material.

Epidemiology

Fusarium organisms occur worldwide.

Infection can develop after:

• Traumatic inoculation

• Ocular exposure

• Surgery

• Contamination of indwelling devices

• Severe disruption of host immunity

The clinical pattern depends strongly on the patient’s immune status.

Risk Factors for Invasive Fusariosis

Severe or disseminated infection is particularly associated with:

• Prolonged neutropenia

• Hematologic malignancy

• Hematopoietic stem-cell transplantation

• Profound immunosuppression

• Indwelling vascular catheters

• Major burns

Neutropenia is an especially important risk factor for disseminated disease.

Skin and Subcutaneous Infection

Localized infection may involve the skin and subcutaneous tissues, particularly following traumatic inoculation.

Manifestations may include:

• Nodules

• Ulcerative lesions

• Necrotic lesions

• Cellulitis-like inflammation

In immunocompromised patients, skin lesions may instead represent hematogenous dissemination.

Keratitis

Fusarium is an important cause of fungal keratitis.

Risk factors can include:

• Corneal trauma

• Exposure to plant or soil material

• Contact-lens-related exposure

• Ocular surface abnormalities

Symptoms may include eye pain, redness, photophobia, and impaired vision.

Endophthalmitis

Fusarium species can cause endophthalmitis, a serious infection involving the internal structures of the eye.

Disease may follow ocular trauma or surgery or occur as part of disseminated infection.

Osteomyelitis and Arthritis

Fusarium may cause:

• Osteomyelitis

• Septic arthritis

These infections have been reported particularly following:

Trauma or surgery

Such infections can be difficult to eradicate and may require combined medical and surgical management.

Peritoneal Dialysis-Associated Peritonitis

Fusarium species can rarely cause peritonitis in patients undergoing peritoneal dialysis.

The dialysis catheter may act as a portal of entry or persistent focus of infection.

Catheter-Associated Infection

Catheter-associated Fusarium infection has been reported particularly in:

• Neutropenic patients

• Patients with major burns

Intravascular devices may contribute to persistent fungemia and may require removal when they represent the infection source.

Disseminated Fusariosis

The most serious manifestation is disseminated fusariosis.

It occurs predominantly in severely immunocompromised patients, particularly those with prolonged neutropenia.

Disease can involve:

• Lungs

• Skin

• Bloodstream

• Sinuses

• Eyes

• Central nervous system

• Multiple other organs

Fusarium vs. Aspergillus

Disseminated fusariosis may clinically resemble invasive aspergillosis, but two findings are especially helpful:

Disseminated

Fusarium

→ Pulmonary and systemic invasive disease

→ Cutaneous lesions are relatively common

→ Fungemia/positive blood cultures can occur

Invasive

Aspergillus

→ Similar angioinvasive pulmonary and disseminated disease

→ Cutaneous lesions are generally less prominent

→ Blood cultures are usually negative

Therefore:

Neutropenia + mold infection + skin lesions + positive blood cultures

→ Strongly consider Fusarium

Cutaneous Lesions in Disseminated Disease

Skin lesions are an important clue to disseminated fusariosis.

They may appear as:

• Painful erythematous papules

• Nodules

• Necrotic lesions

• Lesions with central eschar

Biopsy of a skin lesion can provide a relatively accessible method of obtaining tissue for diagnosis.

Fungemia

Unlike many other invasive molds, Fusarium can produce detectable fungemia.

Thus, blood cultures may occasionally grow the organism in disseminated disease.

This is an important exam distinction from Aspergillus.

Diagnosis

Diagnosis is based on:

Identification of fungal elements in tissue biopsy

and

Culture of the fungus

Histopathology helps establish invasive tissue disease, while culture assists with organism identification.

Histopathology

Tissue examination may demonstrate:

Hyaline, septate fungal hyphae

The appearance can resemble Aspergillus, making culture or molecular identification important for definitive differentiation.

Culture

Culture is particularly useful because Fusarium can grow from:

• Tissue specimens

• Skin lesions

• Respiratory specimens

• Blood in disseminated disease

Species identification and antifungal susceptibility information can help guide management because resistance patterns vary.

Treatment

The source notes that clinical data regarding optimal antifungal therapy were limited and describes:

Intravenous amphotericin B

with or without:

Flucytosine

These recommendations reflect the therapeutic approaches available when the source was written.

Modern Treatment Consideration

Treatment of invasive fusariosis is challenging because Fusarium species can demonstrate substantial and variable antifungal resistance.

Management of serious disease therefore depends on:

Species/isolate identification

• ●

Antifungal susceptibility

• ●

Site and extent of infection

• ●

Host immune status

Recovery from neutropenia or improvement of immunosuppression can be critically important to outcome.

Surgical Management

The source emphasizes that surgical removal of operable lesions may be necessary when antifungal therapy alone is insufficient.

Potential interventions include:

• Debridement of infected tissue

• Removal of localized infected lesions

• Management of infected prosthetic material

• Removal of infected catheters when appropriate

Immune Recovery

In disseminated fusariosis, antifungal therapy alone may be insufficient when profound neutropenia persists.

Therefore:

Antifungal therapy + source control + recovery of host immune function

are major components of successful management.

High-Yield Clinical Pattern

Profoundly neutropenic patient

• ●

Pulmonary/systemic mold infection

• ●

Multiple necrotic skin lesions

• ●

Positive blood culture for a mold

→ Think disseminated Fusarium infection

Ocular Pattern

Corneal trauma or environmental exposure

• ●

Painful inflamed cornea

• ●

Septate filamentous fungus

→ Consider Fusarium keratitis

Exam Essentials

Genus: Fusarium

Type: Filamentous mold

Hyphae: Hyaline and septate

Distribution: Worldwide

Localized infections: Skin/subcutaneous infection, keratitis

Deep infections: Endophthalmitis, osteomyelitis, arthritis

Device association: Peritoneal dialysis and intravascular catheters

Major invasive disease: Disseminated fusariosis

Major risk factor: Prolonged neutropenia

Characteristic disseminated finding: Multiple skin lesions

Blood cultures: May be positive, unlike invasive aspergillosis in most cases

Diagnosis: Tissue biopsy + fungal culture

Treatment challenge: Variable antifungal resistance

Additional management: Surgical source control and catheter removal when appropriate

Prognostic factor: Recovery from neutropenia/immune function is extremely important

Key clinical pearl: The classic clue for disseminated fusariosis is a profoundly neutropenic patient with invasive mold disease, multiple necrotic skin lesions, and fungemia. Unlike Aspergillus, Fusarium can frequently produce positive blood cultures, making this distinction especially useful for examinations.

Infectious Disease and Microbiology – Kyasanur Forest Disease Virus

Overview

Kyasanur Forest disease virus (KFDV) is a tick-borne flavivirus that causes Kyasanur Forest disease (KFD), an acute febrile illness that may progress to hemorrhagic manifestations and neurologic complications.

The disease was first recognized in the Kyasanur Forest region of Karnataka, India, and is primarily associated with forested areas of India.

⸻

Classification

Virus: Kyasanur Forest disease virus

Genus: Flavivirus

Family: Flaviviridae

KFDV belongs to the tick-borne flavivirus group.

⸻

Microbiologic Characteristics

Kyasanur Forest disease virus is:

• Positive-sense, single-stranded RNA virus

• Enveloped

• Approximately spherical

• A member of the family Flaviviridae

Its envelope contains viral proteins important for attachment and entry into susceptible host cells.

⸻

Epidemiology

Kyasanur Forest disease is primarily a zoonotic tick-borne infection associated with forest environments.

The disease is most strongly associated with India, particularly regions where infected ticks, wild animals, and humans come into contact.

Related viruses within the KFDV group have also been recognized elsewhere in Asia and the Arabian Peninsula.

⸻

Transmission

Transmission to humans occurs primarily through the bite of infected hard ticks, particularly Haemaphysalis species.

The virus is maintained in nature through interactions between:

Ticks

Small mammals and other vertebrate hosts

Monkeys

Humans are generally accidental hosts.

⸻

Monkey Association

KFD is sometimes called “monkey fever.”

Monkeys can develop severe or fatal infection, and monkey deaths in forested regions may serve as an epidemiologic warning of viral circulation.

Humans may become infected when they enter areas containing infected ticks.

⸻

Incubation Period

The incubation period is approximately:

3–8 days

Symptoms generally begin abruptly following the incubation period.

⸻

Clinical Infection

Kyasanur Forest disease typically begins as an acute febrile illness.

Common manifestations may include:

• Sudden high fever

• Severe headache

• Myalgia

• Generalized weakness

• Chills

• Nausea and vomiting

Hemorrhagic manifestations may develop in more severe cases.

⸻

Hemorrhagic Manifestations

Patients may develop:

• Petechiae

• Epistaxis

• Gastrointestinal bleeding

• Other mucosal or systemic hemorrhage

Thrombocytopenia and other hematologic abnormalities may accompany severe disease.

⸻

Biphasic Illness

Some patients experience a biphasic course.

After an initial febrile illness and apparent improvement, fever may recur.

The second phase may be accompanied by neurologic manifestations such as:

• Severe headache

• Tremor

• Altered mental status

• Meningoencephalitic features

⸻

Important Terminology Correction

The supplied source describes KFDV as causing:

“Hemorrhagic fever with renal syndrome.”

This terminology should be interpreted cautiously.

Hemorrhagic fever with renal syndrome (HFRS) classically refers to disease caused by hantaviruses, not Kyasanur Forest disease virus.

KFDV instead causes Kyasanur Forest disease, a tick-borne viral hemorrhagic febrile illness.

⸻

Diagnosis

The source lists:

• Cell culture

• Serologic testing

• PCR

Modern diagnosis commonly relies on molecular and serologic methods.

⸻

PCR

RT-PCR can detect viral RNA, particularly during the acute viremic phase.

It provides specific evidence of active infection.

⸻

Serology

Serologic testing can detect the host immune response to KFDV and may be particularly useful after antibodies have developed.

Interpretation depends on the timing of specimen collection and the specific assay used.

⸻

Treatment

Treatment is primarily:

Supportive and symptomatic

There is no routinely established specific antiviral therapy for KFD.

⸻

Supportive Management

Management may include:

• Adequate hydration

• Fever and pain management

• Monitoring of blood counts

• Management of bleeding complications

• Hemodynamic support when required

• Neurologic monitoring in severe disease

Severe cases may require hospitalization and intensive supportive care.

⸻

Prevention

Because KFDV is primarily transmitted by ticks, prevention focuses on reducing tick exposure.

Measures include:

• Protective clothing in forested areas

• Appropriate tick repellents

• Regular examination for ticks

• Avoidance of heavily tick-infested areas when outbreaks occur

• Public-health surveillance in endemic regions

⸻

High-Yield Clinical Pattern

Person exposed to forested areas in endemic India

Tick exposure

Incubation of approximately 3–8 days

Acute fever, severe headache, and myalgia

Possible hemorrhagic manifestations

→ Think Kyasanur Forest disease virus

⸻

Biphasic Pattern

Initial hemorrhagic febrile illness

Temporary improvement

Recurrence with neurologic manifestations

→ Classic potential pattern of Kyasanur Forest disease

⸻

Exam Essentials

Virus: Kyasanur Forest disease virus

Genus: Flavivirus

Family: Flaviviridae

Genome: Positive-sense single-stranded RNA

Envelope: Present

Vector: Tick, particularly Haemaphysalis

Geographic association: Primarily India

Human role: Accidental host

Important animal association: Monkeys

Alternative name: Monkey fever

Incubation: 3–8 days

Disease: Acute febrile illness with possible hemorrhagic and neurologic manifestations

Course: May be biphasic

Diagnosis: RT-PCR and serology; culture historically described

Treatment: Supportive

Important distinction: HFRS is classically a hantavirus syndrome, not the usual name for KFD

⸻

Key clinical pearl: Kyasanur Forest disease virus is a tick-borne flavivirus associated primarily with forest exposure in India and produces an acute febrile illness that may become hemorrhagic and sometimes biphasic with neurologic involvement; do not confuse it with hantavirus-associated hemorrhagic fever with renal syndrome.

Infectious Disease and Microbiology – Flavobacterium Species

Overview

Flavobacterium species are aerobic Gram-negative bacilli historically associated with a variety of opportunistic and healthcare-associated infections. Important manifestations described in older literature include neonatal meningitis and bacteremia, prosthetic-valve endocarditis, contaminated-solution-associated bacteremia, and wound infection.

The taxonomy of this group has changed substantially, so several organisms formerly classified as Flavobacterium now belong to other genera.

Important Species

Historically recognized species include:

• Flavobacterium indologenes

• Flavobacterium meningosepticum

• Flavobacterium odoratum

• Other Flavobacterium species

Several of these names are now considered older taxonomic designations.

Important Taxonomic Changes

A major point when reading older infectious-disease literature is that:

Flavobacterium meningosepticum → now Elizabethkingia meningoseptica

Flavobacterium indologenes → now Chryseobacterium indologenes

Thus, older reports of Flavobacterium infection may actually describe organisms currently classified as Elizabethkingia or Chryseobacterium.

Microbiologic Characteristics

Historically classified Flavobacterium organisms are:

• Aerobic

• Gram-negative bacilli

• Generally environmental organisms

• Capable of causing opportunistic and healthcare-associated infection

The source correctly notes that the taxonomy was unsettled; subsequent reclassification has substantially reorganized these organisms.

Clinical Infections

Reported infections include:

• Meningitis

• Bacteremia

• Prosthetic-valve endocarditis

• Healthcare-associated outbreaks

• Wound infection

Clinical manifestations vary considerably according to the species and host.

Neonatal Meningitis

The organism historically called F. meningosepticum is particularly associated with:

Meningitis in newborns

Neonatal infection can be severe and may occur in healthcare settings.

This organism is now known as Elizabethkingia meningoseptica.

Neonatal Bacteremia

In addition to meningitis, E. meningoseptica can cause neonatal bacteremia and sepsis.

Premature and medically complex newborns may be particularly vulnerable to invasive infection.

Endocarditis

Organisms historically included in the Flavobacterium group have occasionally caused infective endocarditis.

The source particularly emphasizes infection involving:

Prosthetic heart valves

This represents a rare but serious invasive manifestation.

Nosocomial Bacteremia

Healthcare-associated outbreaks of bacteremia have been reported.

A particularly important epidemiologic association is:

Contaminated solutions

Such outbreaks demonstrate the ability of these environmental Gram-negative organisms to contaminate healthcare materials and cause invasive disease in susceptible patients.

Wound Infection

Flavobacterium-group organisms have also been associated with wound infections.

Their clinical significance should be interpreted according to the specimen source, evidence of tissue inflammation, and the patient’s underlying condition.

Diagnosis

Diagnosis is established by:

Culture of the pathogen

Accurate identification is particularly important because:

• Taxonomy has changed

• These are uncommon organisms

• Antimicrobial susceptibility may be unusual

• Resistance to multiple conventional Gram-negative antibiotics can occur

Antimicrobial Susceptibility

A major clinical feature of organisms such as Elizabethkingia meningoseptica is their unusual antimicrobial susceptibility pattern.

They may be resistant to several antibiotics ordinarily used against Gram-negative bacteria.

Therefore, treatment should be based on:

Accurate species identification + antimicrobial susceptibility testing

Treatment

The source lists:

Ciprofloxacin

as a treatment option.

Because susceptibility can vary substantially, modern management of serious infection should be guided by isolate-specific susceptibility testing rather than assuming that a particular agent will always be effective.

Historical Vancomycin Treatment

The source describes reports of successful treatment of neonatal meningitis with:

Vancomycin

This was historically notable because vancomycin ordinarily has little or no useful activity against Gram-negative bacteria.

However, the statement that Flavobacterium is uniquely susceptible to vancomycin reflects older literature and should not be treated as a modern general treatment rule.

Why Vancomycin Is Unusual

Normally:

Gram-negative outer membrane

→ prevents effective penetration of vancomycin

→ intrinsic lack of useful vancomycin activity

Therefore, historical reports involving F. meningosepticum were microbiologically unusual and became a memorable feature of older teaching material.

High-Yield Clinical Pattern

Newborn

• ●

Meningitis or bacteremia

• ●

Unusual aerobic Gram-negative bacillus

• ●

Healthcare-associated setting

→ Think Elizabethkingia meningoseptica

(formerly Flavobacterium meningosepticum)

Nosocomial Pattern

Cluster of bloodstream infections

• ●

Hospitalized patients

• ●

Possible contaminated medical solution

→ Consider an environmental Gram-negative organism historically classified among Flavobacterium

Exam Essentials

Historical genus: Flavobacterium

Type: Aerobic Gram-negative bacilli

Important old species: F. meningosepticum

Current name: Elizabethkingia meningoseptica

Old F. indologenes: Now Chryseobacterium indologenes

Classic severe infection: Neonatal meningitis and bacteremia

Other infection: Prosthetic-valve endocarditis

Nosocomial outbreaks: May involve contaminated solutions

Additional infection: Wound infection

Diagnosis: Culture

Important issue: Unusual and potentially multidrug-resistant susceptibility patterns

Treatment in source: Ciprofloxacin

Historical treatment observation: Vancomycin was reported for neonatal meningitis

Modern treatment principle: Susceptibility-guided antimicrobial therapy

Key clinical pearl: The most important association in older literature is Flavobacterium meningosepticum + neonatal meningitis/bacteremia. Remember that this organism has been reclassified as Elizabethkingia meningoseptica and has an unusual antimicrobial resistance profile, making accurate identification and susceptibility-guided therapy particularly important.

Infectious Disease and Microbiology – Flavimonas oryzihabitans

Overview

Flavimonas oryzihabitans is a rare aerobic Gram-negative bacillus that acts primarily as an opportunistic pathogen. Reported infections are often healthcare-associated and have a notable relationship with intravascular catheters and implanted prosthetic devices.

An important clinical presentation is catheter-associated bacteremia, which may be polymicrobial.

Microbiologic Characteristics

Flavimonas oryzihabitans is:

• An aerobic Gram-negative bacillus

• An uncommon human pathogen

• Primarily associated with opportunistic and healthcare-related infections

The organism has undergone taxonomic reclassification and is now generally known as Pseudomonas oryzihabitans.

Epidemiology

Human infection is rare.

When infection occurs, it is frequently associated with patients who have:

• Intravascular catheters

• Prosthetic devices

• Peritoneal dialysis catheters

• CNS shunts

• Significant underlying medical conditions

These associations suggest that foreign material and disruption of normal host barriers can facilitate infection.

Bacteremia

One of the most important manifestations is bacteremia.

Bloodstream infections may be:

• Polymicrobial

• Associated with intravascular lines

• Healthcare-associated

When the organism is repeatedly isolated from blood in a patient with an intravascular catheter, a catheter-related bloodstream infection should be considered.

Intravascular Line Infection

Intravascular catheters provide a potential surface for bacterial colonization and subsequent bloodstream invasion.

The clinical pattern may be:

Intravascular catheter

• ●

Fever or systemic illness

• ●

Positive blood cultures for F. oryzihabitans

→ Consider catheter-associated bacteremia

Peritoneal Dialysis-Associated Peritonitis

F. oryzihabitans has been reported as a cause of peritonitis in patients undergoing peritoneal dialysis.

Patients may develop:

• Abdominal pain

• Fever

• Cloudy peritoneal dialysis fluid

• Increased inflammatory cells in dialysate

The dialysis catheter may serve as an important portal or persistent source of infection.

CNS Shunt Infection

The organism can infect central nervous system shunts.

Such infections demonstrate its ability to cause disease involving implanted medical devices.

Depending on the clinical situation, management may require both antimicrobial therapy and evaluation of the infected shunt.

Prosthetic Joint Infection

F. oryzihabitans has occasionally been associated with prosthetic joint infection.

Possible manifestations include:

• Joint pain

• Swelling

• Reduced joint function

• Local inflammatory findings

Because prosthetic material is involved, antimicrobial therapy alone may not always provide adequate source control.

Prosthetic Valve Endocarditis

Rare cases of prosthetic valve endocarditis have also been described.

This represents a serious invasive manifestation and should be considered when persistent bacteremia occurs in a patient with a prosthetic cardiac valve.

Meningitis

F. oryzihabitans can rarely cause meningitis.

Diagnosis depends on compatible clinical findings and microbiologic isolation from cerebrospinal fluid or other relevant specimens.

Wound Infection

The organism has also been recovered from wound infections.

Its significance should be interpreted according to the clinical appearance of the wound and the quality of the specimen because an unusual environmental organism recovered from a superficial specimen does not necessarily establish invasive infection.

Diagnosis

Diagnosis is established by:

Culture of the organism

Depending on the clinical syndrome, specimens may include:

• Blood

• Peritoneal dialysis fluid

• Cerebrospinal fluid

• Joint or prosthetic material

• Wound specimens

For significant infections, antimicrobial susceptibility testing can help guide therapy.

Treatment

The source lists an:

Antipseudomonal β-lactam

as a treatment option.

It also lists the carbapenems:

• Imipenem

• Meropenem

Treatment should be individualized according to the infection site, severity, and susceptibility results.

Additional Treatment

Additional agents listed in the source include:

• Ciprofloxacin

• Aminoglycosides

Because this organism is an uncommon pathogen, susceptibility-guided antimicrobial selection is particularly important.

Device-Associated Infection

A major clinical theme is the organism’s association with foreign or prosthetic material:

Intravascular line

Peritoneal dialysis catheter

CNS shunt

Prosthetic joint

Prosthetic heart valve

This association should raise consideration of device-related infection when the organism is recovered from an appropriate clinical specimen.

Source Control

When an implanted device is the suspected source, treatment may require consideration of:

• Catheter removal

• Shunt revision or removal

• Management of infected prosthetic material

• Drainage or debridement when appropriate

The need for device removal depends on the location, severity, persistence of infection, and clinical circumstances.

High-Yield Clinical Pattern

Hospitalized or medically complex patient

• ●

Intravascular catheter or implanted device

• ●

Gram-negative bacillus

• ●

Bacteremia, often polymicrobial

→ Consider Flavimonas oryzihabitans (Pseudomonas oryzihabitans)

Exam Essentials

Organism: Flavimonas oryzihabitans

Current name: Pseudomonas oryzihabitans

Type: Gram-negative bacillus

Oxygen requirement: Aerobic

Frequency: Rare human pathogen

Major infection: Catheter-associated bacteremia

Bacteremia: Frequently polymicrobial in the source

Other infections: Peritoneal dialysis-associated peritonitis, CNS shunt infection, prosthetic joint infection, prosthetic valve endocarditis, meningitis, wound infection

Major association: Indwelling and prosthetic medical devices

Diagnosis: Culture

Treatment in source: Antipseudomonal β-lactam or carbapenem

Additional agents: Ciprofloxacin or aminoglycoside

Management principle: Consider susceptibility-guided therapy and appropriate device/source control

Key clinical pearl: Flavimonas oryzihabitans, now generally called Pseudomonas oryzihabitans, is a rare opportunistic Gram-negative bacillus with a strong association with intravascular lines and other prosthetic devices; catheter-associated, sometimes polymicrobial, bacteremia is a particularly characteristic presentation.

Infectious Disease and Microbiology – Fasciolopsis buski

Overview

Fasciolopsis buski is a large intestinal trematode (fluke) that causes fasciolopsiasis. Unlike Fasciola species, which primarily involve the liver and biliary tract, F. buski primarily inhabits the small intestine.

Infection is concentrated in parts of South and Southeast Asia and usually produces gastrointestinal manifestations. Heavy worm burdens can rarely result in acute intestinal obstruction.

Microbiologic Characteristics

Fasciolopsis buski is:

• A trematode helminth

• An intestinal fluke

• Approximately 7 cm long as an adult

• One of the largest intestinal flukes infecting humans

Adult worms primarily inhabit the small intestine.

Epidemiology

Fasciolopsiasis occurs predominantly in:

• Rural Southeast Asia

• India and other parts of South Asia

Transmission is associated with areas where the parasite’s freshwater life cycle can be maintained.

Transmission

Humans acquire infection by ingesting metacercariae attached to raw or inadequately prepared aquatic vegetation.

Freshwater snails serve as intermediate hosts.

The general transmission cycle is:

Eggs reach freshwater

→

Freshwater snail intermediate host

→

Metacercariae develop on aquatic plants

→

Humans ingest contaminated aquatic vegetation

→

Adult flukes develop in the small intestine

Fasciolopsiasis

The disease caused by F. buski is known as:

Fasciolopsiasis

The severity of disease is related partly to the number of worms present.

Light infections may produce few or no symptoms, whereas heavier infections can cause significant gastrointestinal disease.

Gastrointestinal Manifestations

Clinical manifestations may include:

• Diarrhea

• Constipation

• Vomiting

• Anorexia

• Abdominal discomfort

The parasites can produce local irritation and inflammation of the intestinal mucosa.

Heavy Infection

Heavy parasite burdens can produce more severe gastrointestinal manifestations.

Large numbers of these relatively large flukes may interfere with normal intestinal function.

Acute Intestinal Obstruction

A rare but important complication is:

Acute intestinal obstruction

This is particularly associated with a heavy worm burden.

Thus:

Endemic-area exposure + gastrointestinal symptoms + intestinal obstruction

should raise consideration of heavy F. buski infection.

Diagnosis

Diagnosis is primarily established by:

Parasitologic examination of stool

Characteristic trematode eggs can be detected microscopically.

Stool Examination

Stool microscopy is the principal diagnostic method because adult worms residing in the intestine release eggs that are passed in feces.

The eggs may resemble those of Fasciola species, so clinical and epidemiologic context can assist with interpretation.

Treatment

The source recommends:

Praziquantel 25 mg/kg orally every 8 hours for 1 day

Praziquantel is the major antiparasitic agent associated with treatment of fasciolopsiasis.

Additional Treatment

The source lists:

Niclosamide 2 g orally as a single dose

as an additional treatment option.

Prevention

Prevention centers on interrupting transmission from contaminated freshwater environments.

Important measures include:

• Avoiding raw aquatic vegetation in endemic areas

• Thoroughly cooking aquatic plants

• Safe sanitation and disposal of feces

• Avoiding contamination of freshwater sources

Fasciolopsis vs. Fasciola

Fasciolopsis buski

→ Intestinal fluke

→ Adult worms live in the small intestine

→ Causes fasciolopsiasis

→ Diarrhea, vomiting, anorexia, and possible intestinal obstruction

→ Praziquantel is the classic treatment

Fasciola hepatica / F. gigantica

→ Liver flukes

→ Primarily involve the liver and biliary tree

→ Cause fascioliasis

→ Hepatic migration may produce RUQ pain and eosinophilia

→ Triclabendazole is the key treatment

High-Yield Clinical Pattern

Patient from rural Southeast or South Asia

• ●

Consumption of contaminated aquatic vegetation

• ●

Diarrhea, vomiting, anorexia, or abdominal symptoms

• ●

Large intestinal trematode eggs in stool

→ Think Fasciolopsis buski

Severe Infection Pattern

Heavy intestinal fluke burden

• ●

Acute abdominal symptoms

• ●

Mechanical intestinal obstruction

→ Consider severe Fasciolopsis buski infection

Exam Essentials

Organism: Fasciolopsis buski

Type: Trematode helminth

Common name: Large intestinal fluke

Adult size: Approximately 7 cm

Distribution: Rural Southeast Asia and South Asia

Primary site: Small intestine

Transmission: Ingestion of metacercariae on aquatic vegetation

Intermediate host: Freshwater snail

Disease: Fasciolopsiasis

Major symptoms: Diarrhea, constipation, vomiting, anorexia

Major rare complication: Acute intestinal obstruction

Diagnosis: Parasitologic stool examination

Treatment: Praziquantel 25 mg/kg every 8 hours for 1 day

Alternative in source: Niclosamide

Key clinical pearl: Fasciolopsis buski is a large intestinal fluke acquired from contaminated aquatic vegetation; remember small-intestinal disease + gastrointestinal symptoms + possible obstruction, in contrast to Fasciola species, which primarily cause hepatic and biliary disease.

Infectious Disease and Microbiology – Fasciola Species

Overview

Fasciola species are trematode helminths (liver flukes) that cause fascioliasis, a parasitic infection primarily involving the liver and biliary tract.

The two major species are Fasciola hepatica and Fasciola gigantica. Humans are accidental hosts, while the normal definitive hosts include sheep, cattle, and other herbivorous animals.

⸻

Important Species

The principal human pathogens are:

• Fasciola hepatica

• Fasciola gigantica

F. hepatica is commonly known as the common liver fluke, whereas F. gigantica is generally larger and occurs predominantly in tropical regions.

⸻

Microbiologic Characteristics

Fasciola species are:

• Trematodes (flukes)

• Helminthic parasites

• Leaf-shaped adult worms

• Approximately several centimeters in length

Adult Fasciola organisms inhabit the biliary system of their definitive hosts.

⸻

Epidemiology

Fascioliasis occurs worldwide, although human infection is relatively uncommon.

The parasites naturally infect:

• Sheep

• Cattle

• Other grazing herbivores

Human disease is particularly associated with sheep- and cattle-raising regions where the parasite’s life cycle is maintained.

⸻

Humans as Accidental Hosts

Humans are accidental definitive hosts.

Human infection occurs when infective metacercariae are ingested, classically on contaminated aquatic vegetation.

Ingestion → intestinal penetration → hepatic migration → biliary tract maturation

⸻

Transmission

A classic source of human infection is consumption of raw aquatic plants, particularly watercress, contaminated with metacercariae.

Contaminated water can also serve as a source.

Freshwater snails participate as intermediate hosts in the parasite’s life cycle.

⸻

Fascioliasis

The disease caused by Fasciola species is:

Fascioliasis

It primarily involves the:

Liver

and

Biliary tree

Disease can be divided conceptually into an early hepatic migratory phase and a later biliary phase.

⸻

Acute Hepatic Phase

After ingestion, immature flukes penetrate the intestinal wall and migrate through the peritoneal cavity into the liver.

Migration through hepatic tissue may produce:

• Fever

• Right upper-quadrant abdominal pain

• Hepatomegaly

• Malaise

• Nausea

• Urticaria or other allergic manifestations

• Peripheral eosinophilia

This phase reflects tissue migration rather than established adult worms in the bile ducts.

⸻

Chronic Biliary Phase

After reaching maturity, adult flukes enter the biliary ducts.

Chronic infection may produce:

• Biliary inflammation

• Recurrent right upper-quadrant pain

• Cholangitis

• Biliary obstruction

• Jaundice

Some infections remain relatively asymptomatic.

⸻

Obstructive Cholangitis

Adult flukes may occasionally produce mechanical obstruction of the biliary tract, resulting in obstructive cholangitis.

In this situation, endoscopic intervention may be necessary in addition to antiparasitic treatment.

⸻

Ectopic Fascioliasis

Rarely, Fasciola parasites migrate outside their usual hepatic and biliary locations.

Such ectopic infection has been described particularly with F. gigantica.

Clinical manifestations depend on the organ involved.

⸻

Diagnosis

Diagnosis shares some features with other hepatobiliary fluke infections such as Clonorchis sinensis.

Methods include:

• Parasitologic examination for characteristic eggs

• Serologic testing

• Molecular testing such as PCR for species identification

⸻

Stool Examination

Characteristic Fasciola eggs may be detected in stool once adult parasites have matured in the biliary tract and begun producing eggs.

However, during the early hepatic migratory phase, stool examination may be negative because immature parasites have not yet begun producing eggs.

⸻

Serology

Serologic testing is particularly useful during early infection when clinical manifestations and eosinophilia are present but eggs are not yet detectable in stool.

Thus:

Acute hepatic symptoms + eosinophilia + exposure history + negative stool examination

→ Consider Fasciola serology

⸻

PCR

PCR-based testing can assist with detection and differentiation of Fasciola species where available.

⸻

Treatment

The source reflects older therapeutic information and states that satisfactory antiparasitic treatment was limited.

It describes:

Bithionol 30–50 mg/kg on alternate days for 10–14 doses

as having moderate effectiveness.

⸻

Triclabendazole

The source describes triclabendazole 10 mg/kg as a single dose as a veterinary product that had occasionally been used in humans and was not FDA-approved at the time the source was written.

Importantly, that information is now historically outdated: triclabendazole subsequently became an approved human treatment for fascioliasis in the United States.

It is the key drug associated with treatment of Fasciola infection.

⸻

Praziquantel

The source lists:

Praziquantel

as additional therapy.

However, a major high-yield distinction is that Fasciola species respond poorly to praziquantel, unlike several other trematode infections.

Therefore, the classic treatment association to remember is:

Fascioliasis → triclabendazole

⸻

Endoscopic Treatment

When adult flukes produce significant biliary obstruction or obstructive cholangitis, ERCP (endoscopic retrograde cholangiopancreatography) can be used to identify and remove parasites from the biliary tract.

Thus, severe mechanical obstruction may require:

Antiparasitic treatment + endoscopic source control

⸻

High-Yield Clinical Pattern

Sheep/cattle-raising region

Raw aquatic vegetation or watercress exposure

Right upper-quadrant pain and hepatomegaly

Marked eosinophilia

→ Think Fasciola hepatica or Fasciola gigantica

⸻

Chronic Disease Pattern

Biliary colic or cholangitis

Adult liver fluke in the biliary tree

Characteristic eggs in stool

→ Think chronic fascioliasis

⸻

Fasciola vs. Clonorchis

Fasciola

→ Infection classically from aquatic vegetation/watercress

→ Migrates through liver parenchyma

→ Acute phase commonly associated with eosinophilia

→ Treatment classically associated with triclabendazole

Clonorchis sinensis

→ Infection from raw or undercooked freshwater fish

→ Primarily inhabits the biliary ducts

→ Chronic infection associated with cholangiocarcinoma

→ Typically treated with praziquantel

⸻

Exam Essentials

Genus: Fasciola

Species: F. hepatica, F. gigantica

Type: Trematode/liver fluke

Natural hosts: Sheep, cattle, and other herbivores

Human role: Accidental host

Intermediate host: Freshwater snail

Classic exposure: Raw aquatic vegetation, especially watercress

Primary organs: Liver and biliary tree

Acute phase: Hepatic migration

Important laboratory clue: Eosinophilia

Chronic phase: Biliary disease

Diagnosis: Stool examination, serology, and molecular methods where available

Early infection: Stool may be negative

Key treatment association: Triclabendazole

Praziquantel: Poor activity against Fasciola

Biliary obstruction: May require ERCP and parasite removal

⸻

Key clinical pearl: Think Fasciola when a patient with raw watercress/aquatic-plant exposure develops right upper-quadrant pain, hepatomegaly, and eosinophilia. Unlike many other trematodes, the key treatment is triclabendazole rather than praziquantel.

Infectious Disease and Microbiology – Exophiala Species

Overview

Exophiala species are dematiaceous (darkly pigmented) filamentous fungi that are distributed worldwide. They are uncommon causes of human disease but can produce cutaneous, subcutaneous, ocular, pulmonary, and invasive systemic infections.

Because of their melanin-containing cell walls and pigmented hyphae, infections caused by these organisms are generally classified among the phaeohyphomycoses.

Important Species

Clinically recognized species include:

• Exophiala dermatitidis

• Exophiala jeanselmei

• Exophiala moniliae

• Exophiala pisciphila

• Exophiala spinifera

Different species vary in their clinical associations and potential for invasive disease.

Microbiologic Characteristics

Exophiala species are:

• Dematiaceous fungi

• Filamentous molds

• Characterized by dark pigmentation related to melanin in the fungal cell wall

In infected tissue, they may appear as:

• Yeast-like forms

• Pseudohyphae

• Septate pigmented hyphae

Dematiaceous Fungi

The term dematiaceous refers to fungi with brown-to-black pigmentation in their cell walls.

When these pigmented fungi produce infection characterized by yeast-like cells, pseudohyphae, or irregular pigmented hyphae in tissue, the disease is generally termed:

Phaeohyphomycosis

Epidemiology

Exophiala species have a worldwide distribution.

Despite their environmental distribution, human infections are rare.

Disease may remain localized or, particularly in susceptible hosts, become invasive.

Clinical Infections

Reported infections include:

• Corneal infection

• Cutaneous and subcutaneous infection

• Prosthetic valve endocarditis

• Septic arthritis

• Brain abscess

• Pneumonia

• Other systemic infections

The clinical spectrum therefore ranges from localized superficial disease to potentially severe invasive infection.

Corneal Infection

Exophiala species can occasionally cause fungal keratitis.

Clinical manifestations may include:

• Eye pain

• Redness

• Photophobia

• Decreased vision

• Corneal inflammation or ulceration

A history of ocular trauma or environmental exposure may provide a clue to fungal infection.

Subcutaneous Infection

One of the better-recognized manifestations is subcutaneous phaeohyphomycosis.

Patients may develop:

• Slowly enlarging nodules

• Cysts

• Abscess-like lesions

• Chronic localized swelling

Traumatic implantation of environmental fungal material into the skin or subcutaneous tissue may initiate infection.

Pneumonia

Pulmonary infection due to Exophiala species is uncommon but has been reported.

Manifestations can range from chronic respiratory infection to invasive pneumonia, depending on the species and host factors.

Prosthetic Valve Endocarditis

Rare cases of Exophiala-associated prosthetic valve endocarditis have been reported.

This represents a serious invasive infection and may be difficult to eradicate because both fungal infection and infected prosthetic material are involved.

Septic Arthritis

Exophiala species have occasionally been associated with fungal arthritis.

Diagnosis generally requires demonstration of the fungus in synovial fluid or tissue together with compatible clinical findings.

Brain Abscess

One of the most serious manifestations is cerebral infection with brain abscess formation.

Certain dematiaceous fungi have a notable ability to cause central nervous system disease.

Neurologic manifestations may include:

• Headache

• Altered mental status

• Focal neurologic deficits

• Seizures

Systemic Infection

Although uncommon, disseminated or systemic Exophiala infection can occur and may involve multiple organs.

Invasive disease is potentially life-threatening and requires accurate species identification and antifungal management.

Diagnosis

Diagnosis is based on:

Culture of the fungus

and

Histopathologic examination of infected tissue

Using both methods can help establish that the recovered fungus represents true tissue infection.

Histopathology

Histopathologic examination may demonstrate:

Pigmented yeast-like cells

• ●

Pseudohyphae

• ●

Septate, darkly pigmented hyphae

These findings are characteristic of phaeohyphomycosis caused by dematiaceous fungi.

Culture

Fungal culture allows isolation and identification of Exophiala species.

Because treatment response may vary between species and isolates, accurate identification and, in severe disease, consideration of antifungal susceptibility information can be valuable.

Treatment

The source describes treatment with:

Amphotericin B

with or without:

Flucytosine

The optimal treatment depends on the site and severity of infection.

Additional Treatment

The source also lists:

Itraconazole

as an alternative antifungal agent.

Localized disease and invasive systemic infection may require substantially different therapeutic approaches.

Surgical Management

For localized subcutaneous lesions, abscesses, infected prosthetic material, or cerebral lesions, surgical management may sometimes be required in addition to antifungal therapy.

Management of invasive disease should therefore consider both antifungal treatment and appropriate source control.

High-Yield Clinical Pattern

Chronic subcutaneous cyst or nodule

• ●

Dematiaceous fungus

• ●

Pigmented septate hyphae in tissue

→ Think phaeohyphomycosis due to Exophiala species

Invasive Disease Pattern

Pigmented fungus

• ●

Pneumonia, prosthetic valve endocarditis, arthritis, or brain abscess

→ Consider invasive Exophiala infection

Exam Essentials

Genus: Exophiala

Type: Dematiaceous filamentous fungus

Pigment: Melanin-containing/dark fungal elements

Tissue morphology: Yeasts, pseudohyphae, and septate pigmented hyphae

Distribution: Worldwide

Frequency: Rare human pathogen

Disease category: Phaeohyphomycosis

Localized infections: Corneal and subcutaneous disease

Invasive infections: Pneumonia, arthritis, endocarditis, brain abscess

Diagnosis: Fungal culture + histopathology

Treatment in source: Amphotericin B ± flucytosine

Additional treatment: Itraconazole

Management consideration: Surgical intervention/source control may be necessary for selected localized or invasive lesions

Key clinical pearl: Exophiala species are dematiaceous fungi causing phaeohyphomycosis, recognized by pigmented septate hyphae, yeast-like forms, or pseudohyphae in tissue; although infection is usually rare and localized, these organisms can occasionally produce severe disease such as prosthetic valve endocarditis, pneumonia, and brain abscess.